Celebrex® Will Carry New Warning In Australia

Return to Celebrex® homepage on SSEM.COM

The Therapeutic Goods Administration (TGA) in Australia has introduced new restrictions on the painkiller,Celebrex®. The drug, which is taken by 300,000 Australians, has been found to increase the risk of heart problems.

A TGA review of Celebrex® has resulted in Pfizer being told to put warnings of heart risks on their product information.

Chair of the Australian Drug Evaluation Committee, Professor Martin Tattersall says people taking high doses of the drug should review treatment with their doctors.

"The risk is something which now has changed the balance in favor of reducing the use of this drug by dose and reducing the duration of drug treatment," he said.

Tattersall says Celebrex® should only be prescribed when alternative therapies are found to cause serious side-effects.

Pfizer says it has received the decision on the warning changes.

If you believe that you or a relative were injured by taking Celebrex® please use the form below to contact our law firm.

Have you suffered a heart attack or stroke? (Select Yes or No)
YES
NO

Your Name:

Your E-Mail:

Your Daytime Phone Number:

Your Evening Phone Number:

Please fill in your question or comments:

References

Copyright © 1999-2008 Specter Specter Evans & Manogue, P.C.
Terms of Use | Privacy Policy